155 Results for "

3CL

" in MedChemExpress (MCE) Product Catalog:
Products (155)

155 Results for "3CL" in MCE Product Catalog:

111
111 Publications Verification
Cat. No.: HY-138687
CAS No.: 2628280-40-8
Purity:  99.74%
Synonyms: PF-07321332
Target:  

SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV 3C-like protease (3CL PRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-10235
CAS No.: 402957-28-2
Purity:  99.54%
Synonyms: VX-950
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide [3]. Telaprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
42
42 Cited Publications
Cat. No.: HY-13324
CAS No.: 218600-53-4
Purity:  98.92%
Synonyms: RTA 402; NSC 713200; CDDO Methyl ester
Bardoxolone methyl (RTA 402) is an orally active and blood-brain-barrier-penetrant activator of Nrf2 and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone methyl inhibits SARS-CoV-2 replication in Vero cells with an EC50 value of 0.29 μM. Bardoxolone methyl increases levels of pNrf2 and HO-1, inhibits inflammatory mediators like pNFκB and MCP-1. Bardoxolone methyl activates the Nrf2 pathway to enhance antioxidant and anti-inflammatory responses, inhibits viral replication, and improves mitochondrial function. Bardoxolone methyl can be used in research on chemotherapy-induced neuropathic pain (CINP), COVID-19, and chronic kidney disease (CKD) [3] .
loading...
    loading...
42
42 Cited Publications
Cat. No.: HY-14434
CAS No.: 630420-16-5
Purity:  99.84%
Synonyms: BMS-650032
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Asunaprevir (BMS-650032) is a potent and orally bioavailable hepatitis C virus (HCV) NS3 protease inhibitor, with IC50 of 0.2 nM-3.5 nM . Asunaprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
34
34 Cited Publications
Cat. No.: HY-10237
CAS No.: 394730-60-0
Purity:  98.52%
Synonyms: EBP 520; SCH 503034
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay [3] . Boceprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-90001
CAS No.: 155213-67-5
Synonyms: ABT 538; RTV
Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.61 μM. Ritonavir (ABT 538) can penetrate the blood brain barrier (BBB) [3] .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-15602
CAS No.: 1256388-51-8
Purity:  99.69%
Synonyms: GS-5885
Target:  

HCV SARS-CoV

Research Areas:  

Infection

Ledipasvir (GS-5885) is an inhibitor of the hepatitis C virus NS5A, with EC50s of 34 pM and 4 pM against genotype 1a and 1b replicon, respectively. Ledipasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.62 μM [3].
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15298
CAS No.: 1350514-68-9
Purity:  99.99%
Synonyms: MK-5172
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15298A
CAS No.: 1206524-86-8
Purity:  99.63%
Synonyms: MK-5172 potassium salt
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Grazoprevir potassium salt (MK-5172 potassium salt) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir potassium salt inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15298B
CAS No.: 1350462-55-3
Purity:  99.99%
Synonyms: MK-5172 hydrate
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Grazoprevir hydrate (MK-5172 hydrate) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir hydrate inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-14588
CAS No.: 192725-17-0
Purity:  99.71%
Synonyms: ABT-378
Target:  

HIV HIV Protease SARS-CoV

Research Areas:  

Infection Neurological Disease Cancer

Lopinavir (ABT-378) is a highly potent, selective peptidomimetic inhibitor of the HIV-1 protease, with Kis of 1.3 to 3.6 pM for wild-type and mutant HIV protease. Lopinavir acts by arresting maturation of HIV-1 thereby blocking its infectivity . Lopinavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 14.2 μM [3].
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-10238
CAS No.: 850876-88-9
Purity:  99.67%
Synonyms: ITMN-191; R7227; RO5190591; RG7227
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases (IC50 higher than 10 μM). Danoprevir (ITMN-191) inhibits HCV genotypes 1a, 1b, 4, 5, and 6 (IC50s=0.2-0.4 nM) as well as 2b and 3a (IC50s=1.6, 3.5 nM) . Danoprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 0.05 μM [3].
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-N0063
CAS No.: 65995-63-3
Punicalagin is a polyphenol ingredient isolated from Pomegranate (Punica granatum L.) or the leaves of Terminalia catappa L.. Punicalagin is a reversible and non-competitive 3CL pro inhibitor and inhibits SARS-CoV-2 replication in vitro. Punicalagin is an anti-hepatitis B virus (HBV) agent and has antioxidant, anti-inflammatory, and anticancer effects. Punicalagin has the potential for the research of COVID-19 [3].
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-143216
CAS No.: 2647530-73-0
Purity:  99.22%
Synonyms: S-217622
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Ensitrelvir (S-217622) is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM) .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-143216A
CAS No.: 2757470-18-9
Purity:  99.99%
Synonyms: S-217622 fumarate
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Ensitrelvir (S-217622) fumarate is the first orally active non-covalent, non-peptidic, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM) .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-17367
CAS No.: 198904-31-3
Synonyms: BMS-232632
Atazanavir (BMS-232632) is a highly selective and orally active HIV-1 protease inhibitor . Atazanavir is a substrate and inhibitor of CYP3A4, and an inhibitor of P-glycoprotein (P-gp). Atazanavir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 3.49 μM. Atazanavir inhibits cardiac fibrosis, hyperlipidemia and induces malignant glioma death [3] .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-17367A
CAS No.: 229975-97-7
Synonyms: BMS-232632 sulfate
Atazanavir (BMS-232632) sulfate is a highly selective and orally active HIV-1 protease inhibitor with blood-brain barrier permeability. Atazanavir sulfate is a substrate and inhibitor of CYP3A4, and an inhibitor of P-glycoprotein (P-gp). Atazanavir sulfate is also a SARS-CoV 3CL pro inhibitor with an IC50 of 3.49 μM. Atazanavir sulfate inhibits cardiac fibrosis, hyperlipidemia and induces malignant glioma death [3] .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-12594
CAS No.: 1216941-48-8
Purity:  99.87%
Synonyms: ABT-450; Veruprevir
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.31 μM. Paritaprevir is metabolized primarily by cytochrome P450 (CYP) 3A. The plasma concentration and half-life of Paritaprevir can be enhanced by Ritonavir (a CYP450 inhibitor) [3] .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-15148
CAS No.: 174484-41-4
Purity:  ≥98.0%
Synonyms: PNU-140690
Target:  

HIV Protease HIV SARS-CoV

Research Areas:  

Infection

Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM . Tipranavir inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-17634
CAS No.: 1365970-03-1
Synonyms: ABT-493
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging from 3.5 to 11.3 nM. Glecaprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 4.09 μM .
loading...
    loading...